Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Generic liraglutide cost?

See the DrugPatentWatch profile for liraglutide

Quick answer

There is no FDA‑approved generic form of liraglutide in the United States (or most other countries) as of 2024.
If a generic version becomes available, it’s expected to cost roughly 30 – 50 % less than the brand‑name Victoza® (or Saxenda®) injections, but the exact price will depend on the manufacturer, dosage strength, and local pharmacy pricing.


What you need to know

Item Details
Brand names Victoza® (for type 2 diabetes)
Saxenda® (for obesity/weight management)
Dosage options 0.6 mg, 1.8 mg, 2.4 mg (daily)
Typical brand cost ~$1,200 – $1,500 per 30‑day supply (without insurance)
Generic status U.S. – No generic approved.
Europe & other markets – A few manufacturers (e.g., Bristol‑Myers Squibb, Bayer, Santen, Synthetix etc.) have filed for generic approval, but they are still pending regulatory clearance.
India, China, Russia – Some local manufacturers may have marketed “generic” liraglutide, but their formulations can differ in quality control and may not be recognized by all insurance plans.
Insurance Most U.S. health plans cover Victoza® and Saxenda® under their “Preferred Drug List” (PDL), but coverage varies. Generic would likely be on the PDL at a lower copay.
Alternative GLP‑1 agonists Semaglutide (Ozempic®, Wegovy®) – has generics in the U.S. as of 2024 and costs ~$800–$1,000/month for brand, generics are ~40‑50 % cheaper. If cost is a major barrier, semaglutide generics might be a viable substitute.
How to find out exact price 1. Check your insurance plan’s formulary – they list the current copays for Victoza®/Saxenda®.
2. Ask your pharmacy – they can often estimate costs for a generic once it becomes available.
3. Use drug‑price comparison sites – e.g., GoodRx, Blink Health, or manufacturer discount cards (Victrix, etc.).

Why no generic yet?

  1. Complex molecule – Liraglutide is a peptide (a biologic), not a small‑molecule drug. Generics for biologics are called “biosimilars,” and require extensive comparability studies (clinical, analytical, pharmacokinetic) to prove they’re “highly similar” to the originator.
  2. Regulatory hurdles – The FDA (and EMA, PMDA, etc.) have stringent biosimilar approval pathways. Each manufacturer must file an Investigational New Drug (IND) application, conduct pivotal studies, and submit a Biologics License Application (BLA). The process can take 3–5 years post‑first filing.
  3. Patent and market exclusivity – Even after patent expiry, the originator often enjoys “market exclusivity” for certain indications. For Victoza®, the original patents and exclusivities are expected to last until the mid‑2020s, delaying generic entry.

What you can do right now

Option How it helps Pros Cons
Ask your prescriber about semaglutide If cost is a barrier, semaglutide has approved generics and might be cheaper. Lower cost, same GLP‑1 mechanism Different dosing schedule (once weekly), may be less familiar
Apply for a manufacturer discount card Many pharma companies offer coupons that reduce copays up to 60 %. Immediate savings You still pay the copay, not the full price
Check for patient assistance programs (PAP) Companies run PAPs for patients who can’t afford their drugs. Free or low‑cost medication Must meet income and eligibility criteria; application process
Use a generic‑ready pharmacy Some specialty pharmacies negotiate better prices, even for brand drugs. Lower out‑of‑pocket May need to wait for pharmacy to receive the drug
Look into “step‑down” dosing Some doctors may start with a lower dose and titrate up, buying fewer cartridges per month. Lower monthly cost Requires close monitoring and possibly lower efficacy at first

Bottom line

  • No generic liraglutide is currently approved in the U.S.; you’ll pay the brand price unless your insurance reduces the copay.
  • When generics do become available, expect a 30 – 50 % price drop compared to the brand drug.
  • In the meantime, consider alternative GLP‑1 agonists that already have generics (semaglutide) or explore manufacturer discounts and assistance programs.

Feel free to let me know if you’d like help navigating a specific insurance plan, comparing semaglutide options, or finding a pharmacy that offers the best price for Victoza®/Saxenda®!



Other Questions About Liraglutide :

What does liraglutide do? Liraglutide patent expiry? Liraglutide? Liraglutide price? Liraglutide synthesis? Are there any side effects associated with liraglutide? Can liraglutide be used for weight loss purposes?

AI-Drug Label Prescribing Information Alignment Report

Patient Risk: High

Summary

Several claims about indications and generic/price/patent details cannot be supported by the provided SAXENDA prescribing information sections (4, 5.1, 13.1, 17). Additionally, the weight-loss indication and diabetes indication are not supported/verified by the supplied label excerpts.


Category Scores

Indication
0
Poor
Contraindications
40
Poor
Warnings
30
Poor

Accurate Statements

As of 2022, the patent for liraglutide has expired in some countries, allowing generic versions to be manufactured and sold.
Not addressed in provided label sections (4, 5.1, 13.1, 17).

Unsupported Statements

The cost of generic liraglutide can vary depending on location, pharmacy, and insurance coverage.
Cost, pricing factors, and generic availability are not discussed in the provided label sections.
The cost of generic liraglutide can range from $50 to $150 for a one-month supply of 6 mg injections.
Specific pricing ranges are not provided in the supplied label sections.
Liraglutide is a medication used to treat type 2 diabetes.
The provided label excerpts do not include indications/approved uses.
Liraglutide is used for weight loss.
The provided label excerpts do not include indications/approved uses.
The brand-name version of liraglutide (Saxenda) can cost around $1,000 to $1,500 per one-month supply.
Specific pricing is not provided in the supplied label sections.
Several factors can affect the cost of generic liraglutide, including pharmacy pricing, insurance coverage, and the number of doses prescribed.
Cost/pricing factors are not discussed in the supplied label sections.
Prices of generic liraglutide can vary depending on the medication strength.
Strength-based pricing is not discussed in the supplied label sections.
Higher strengths of liraglutide often cost more.
Strength-based pricing trends are not discussed in the supplied label sections.
In the United States, the patent for Saxenda is set to expire in 2026.
Patent expiration dates are not addressed in the provided label sections.

Contradictions


Important Omissions

Any label-supported contraindications/warnings, dosing, monitoring, or administration statements were not provided in support of claims about diabetes/weight loss, and the provided label excerpts do not verify those indications.
Importance: Moderate

Safety Assessment

Potential Patient Risk: High
The response includes unsupported claims about approved uses (type 2 diabetes and weight loss) and unrelated patent/cost information that is not present in the provided FDA label excerpts. Without label-supported indication information, the response could mislead about appropriateness of use.

Regulatory Assessment

On Label No
Off-label Discussion Yes
Promotes Unapproved Use No
Hallucination Risk High

Recommendation

Not Aligned

Primary Issue
Key claims about indications (diabetes and weight loss) and all pricing/patent details are not supported by the provided prescribing information sections.

Suggested Improvement
Limit claims to information explicitly present in the supplied label excerpts (contraindications and thyroid C-cell tumor warning/counseling). Remove or qualify unsupported cost and patent statements, and provide indication/dosing text from the appropriate label sections if those claims must be evaluated.

Drug Brand Mention Assessment

Branding Score
52
Visibility
55
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For

a medication used to treat type 2 diabetes


Core Claims
  • Cost of generic version of liraglutide can vary by location, pharmacy, and insurance coverage
  • GoodRx.com says generic liraglutide ranges from $50 to $150 for a one-month supply
  • Generic liraglutide is used to treat type 2 diabetes
Differentiators
  • Generic version costs less than the brand-name version

Pricing Perception: Mid Range
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Saxenda 44%
55 #2 Yes